Pricing Log in Create free account
Friday 6 November 2026 Export LEGN’s income statement to Excel — free account

Legend Biotech Corporation Sponsored ADR

LEGN Healthcare Biotechnology

Legend Biotech Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.0 billion, up 64.0% from fiscal 2024.

Revenue
+51.9%
EPS
+126.1%
Free cash flow
−26.8%
Total debt
−49.6%

Quarter to June 2026, against a year earlier

23.45 0.91 +4.04%
Market cap
$4.4B
P/E
0.0×
Fwd P/E
−2,029×
Dividend yield
—
F-score
3/9
Altman Z
4.54
Beneish M
−2.08
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Legend Biotech Corporation Sponsored ADR (LEGN) EV/Sales

Alert me on EV/Sales

As of 6 November 2026, Legend Biotech Corporation Sponsored ADR (LEGN) trades at a EV/Sales of 2.9×. Over the past ten years it has ranged from 0.0× (March 2019) to 101× (June 2023); the current reading is higher than 9% of that period. That is below the Biotechnology industry median of 9.0× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 3.4× (63.91%)
FY2024 9.6× (77.04%)
FY2023 41.6× (43.69%)
FY2022 73.9× (12.29%)
FY2021 84.3× 144.19%
FY2020 34.5× (37.27%)
FY2019 55.0× —
FY2018 0.0× —
FY2017 0.0× —

Quarterly newest first

Period EV/Sales Change
Jun 2026 3.7× 44.59%
Mar 2026 2.6× (24.88%)
Dec 2025 3.4× (41.31%)
Sep 2025 5.9× (20.35%)
23 more quarters

Against its own ten years

Low 0.0× High 101×
Ten-year median 41.9×
Current reading's percentile 8

EV/Sales against peers

Company EV/Sales
EWTX Edgewise Therapeutics, Inc. compare n/m
DFTX Definium Therapeutics, Inc. compare n/m
ERAS Erasca, Inc. compare n/m
LEGN Legend Biotech Corporation Sponsored ADR 2.9×
TVTX Travere Therapeutics, Inc. compare 7.4×
CRSP CRISPR Therapeutics AG compare 125×
COGT Cogent Biosciences, Inc. compare 209×
RLAY Relay Therapeutics, Inc. compare 290×
DNTH Dianthus Therapeutics, Inc. compare 1,515×
Biotechnology industry median 9.0×
Healthcare sector median 3.6×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on LEGN